New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

The Alzheimer's Accountability and Investment Act (Public Law 118-93), enacted on October 1, 2024, mandates that the National ...

The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.

Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease ...

Experts say there are ways to reduce our risk of dementia, including diet and exercise, protecting against hearing loss, and ...

ProMIS Neurosciences Inc. (Nasdaq: PMN) (ProMIS), a clinical-stage biotechnology company focused on the generation and ...

This discovery is significant because there are currently no effective treatments for any type of dementia, including FTD.